24.65
0.00 (-0.02%)
| Previous Close | 24.65 |
| Open | 24.63 |
| Volume | 1,068,309 |
| Avg. Volume (3M) | 1,183,640 |
| Market Cap | 1,150,284,928 |
| Price / Sales | 1.63 |
| Price / Book | 1.48 |
| 52 Weeks Range | |
| Earnings Date | 11 May 2026 |
| Profit Margin | -55.80% |
| Operating Margin (TTM) | 6.15% |
| Diluted EPS (TTM) | -8.27 |
| Quarterly Revenue Growth (YOY) | 0.80% |
| Total Debt/Equity (MRQ) | 16.79% |
| Current Ratio (MRQ) | 2.57 |
| Operating Cash Flow (TTM) | 134.40 M |
| Levered Free Cash Flow (TTM) | 131.31 M |
| Return on Assets (TTM) | 2.26% |
| Return on Equity (TTM) | -36.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Avanos Medical, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -5.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.63 |
|
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 3.80% |
| % Held by Institutions | 96.13% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Clark Estates Inc/Ny | 31 Dec 2025 | 888,880 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DELGADO SIGFRIDO | - | 24.65 | -4,264 | -105,108 |
| GALOVAN SCOTT MICHAEL | - | 24.65 | -4,228 | -104,220 |
| Aggregate Net Quantity | -8,492 | |||
| Aggregate Net Value ($) | -209,328 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 24.65 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DELGADO SIGFRIDO | Officer | 22 Apr 2026 | Disposed (-) | 4,264 | 24.65 | 105,108 |
| GALOVAN SCOTT MICHAEL | Officer | 22 Apr 2026 | Disposed (-) | 4,228 | 24.65 | 104,220 |
| Date | Type | Details |
|---|---|---|
| 03 Feb 2026 | Announcement | CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |